BridgeMD
New treatment option for Carpal Tunnel Syndrome
Official title Finnish Carpal Tunnel Surgery Study
ClinicalTrials.gov ID: NCT07614425
What this study is testing
- What it's testing
- Carpal tunnel syndrome (CTS) is a common condition caused by pressure from a ligament on a nerve in the wrist, leading to pain, numbness, and weakness in the hand. Surgery to cut the ligament is often recommended when non-surgical treatments do not provide sufficient symptom relief, but it is unclear how much of the improvement is due to the surgery itself versus natural recovery or placebo effects.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age 18-75 years
- Clinical manifestations of carpal tunnel syndrome: paresthesia and /or hypoesthesia in the distribution of the median nerve, possibly pain
- Electrodiagnostically (ENMG or ENEG) verified compression of the median nerve at the carpal tunnel in the wrist, performed no more than a year before...
- Duration of symptoms 3 months or longer
- Patient living independently
You likely can't join if
- Work disability
- Clinical findings of Abductor Pollicis Brevis atrophy
- Symptoms and Electrodiagnostic findings of some other peripheral neural entrapment than carpal tunnel syndrome
- Rheumatoid arthritis or other forms of systemic inflammatory disease
- Diagnosed dementia
- Neurologic disorders affecting the function of the hand
See the full eligibility criteria
- Age 18-75 years
- Clinical manifestations of carpal tunnel syndrome: paresthesia and /or hypoesthesia in the distribution of the median nerve, possibly pain
- Electrodiagnostically (ENMG or ENEG) verified compression of the median nerve at the carpal tunnel in the wrist, performed no more than a year before recruitment.
- Duration of symptoms 3 months or longer
- Patient living independently
- Patient has not responded to the use of a resting splint supporting the wrist, nor to other possible conservative forms of treatment
- Patient able and willing to give consent
- The patient is willing to undergo surgical treatment for carpal tunnel syndrome.
- The patient has access to a device that can be used to complete electronic symptom questionnaires.
- Work disability
- Clinical findings of Abductor Pollicis Brevis atrophy
- Symptoms and Electrodiagnostic findings of some other peripheral neural entrapment than carpal tunnel syndrome
- Rheumatoid arthritis or other forms of systemic inflammatory disease
- Diagnosed dementia
- Neurologic disorders affecting the function of the hand
- Other untreated systemic disorders or diseases with poor therapeutic balance: hypertension, epilepsy, pulmonary or cardiac disease, liver or renal insufficiency, diabetes mellitus, hypothyroidism, psychiatric disease
- Other causes of pain and paresthesia in the hand
- Previous trauma of the hand or wrist (e.g. distal radius fracture), which has resulted in compromised hand function
- Previous carpal tunnel release in either hand
- Previous nerve injury to the upper limb or cervical spine
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Finland
- Tampere, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Finland; Tampere, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.